EVQLV

12 employees

Leveraging advances in computation to revolutionize the design and development of therapeutic antibodies for biopharma

Basic info

biotechnology research

Biotechnology

Artificial Intelligence

Pharmaceutical

Machine Learning

Life Science

2019

EVQLV raised undisclosed on August 24, 2023

Investors: Endeavor Miami